NEW DELHI: Union health minister Harsh Vardhan para koikena janaishe ki sob manu kun khan Bharat Biotech’s vaccine Covaxin pabole ase tai khan ke bisarikena trials nishena sabole ase.
Harsh Vardhan para koikena janaishe etu manu khan kotha olai thaka toh janibole nimete dib ki emergency use authorization (EUA) Covaxinn toh alag condition te ase clinical trial mode te.
Tai para aro bi koikena janaishe”EUA covaxin nimete covishield para alag ase kile koile toh etu chula toh clinical trial mode te thakibo.sob covaxin paa manu khan ke bisaribo aro sabo judi tai khan trial te thakishe koile toh.”
Minister para aro bi koikena janaishe Covaxin’s approval toh ‘monitored approval’ ase etu toh strick follow up aro rolling review khan thakishe.
Minister para koikena janaishe ki”etu approval para dikhaishe India logote additional vaccine shield ase arsenal te etu bi potential mutant strains dynamic pandemic situation te.etu toh ekta strategic decision ase vaccine security nimete.
Etu vaccine approval te doubt kurikena jawab diya te harsh Vardhan para koikena janaishe World Health Organization para covisheild aro covaxin laga indian approval nimete welcome kurishe.
Tai para koikena janaishe “Hon’blePM Narendra Modi ke khushi janaishe India ke re-establish kura duniya laga vaccine capital bona nimete. Anti-national comments & cynicism opposition laga nadhika nishena ase WHO PARA covishield aro covaxin laga indian approval ke welcome kurishe.sob manu tayari thakibi.
Minister para aro bi tweet kurishe ki”pura duniya india nimete khushi pai ase emergency approval diya nimete Serum Institute of India and Bharat Biotech vaccines ke etu bi safety, efficacy & immunogenicity etu para scientific capability & innovation ecosystem dikhaikena.India khan etu jita toh celebrate kuri ase hoilebi Opposition khan khushi paanai.
Add Comment